Prime award
COLLABORATIONS PHARMACEUTICALS, INC. · Department of Health and Human Services
IS TO DEVELOP PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICATION COMPLEX BY DEMONSTRATING PYRONARIDINE AS A VIABLE SINGLE DOSE TREATMENT FOR EBOLA INFECTION IN NON-HUMAN PRIMATES TO JUSTIFY FURTHER IN VIVO STUDIES FOR U
Current value$2.0M
Obligated to date$0
Months remaining3
Sign in to mark this as watching, pursuing, or passed — and to be told when its end date changes.
Recompete signal
This award ends in 3 months.
Award record
| Field | Value |
|---|---|
| Recipient | COLLABORATIONS PHARMACEUTICALS, INC. |
| Awarding agency | Department of Health and Human Services |
| NAICS | 541714 |
| PSC | AN12 |
| Place of performance | NC |
| Period | → Dec 29, 2026 |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Competition | D |
| Offers received | 4 |
| Vehicle | Standalone |
Data & sources
Record as published by USAspending.gov, vintage FY2021–FY2025 full archives · USAspending.gov, retrieved Aug 6, 2026. Values change as modifications are reported; obligations may be negative when work is de-obligated.